Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
Clinical trial NCT06371040 · RECRUITING
Trial details
- NCT number
- NCT06371040
- Sponsor
- Ting Chang, MD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-12
- Primary completion
- 2025-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.